更多...
收起
The protein encoded by this gene, glutathione S-transferase (GST) theta 1 (GSTT1), is a member of a superfamily of proteins that catalyze the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds. Human GSTs can be divided into five main classes: alpha, mu, pi, theta, and zeta. The theta class includes GSTT1 and GSTT2. GSTT1 and GSTT2 share 55% amino acid sequence identity and both may play an important role in human carcinogenesis. The GSTT1 and GSTT2 genes have a similar structure, being composed of five exons with identical exon/intron boundaries. This GSTT1 gene is haplotype-specific and is absent from 38% of the population. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes, which are also located on chromosome 22, have been identified. [provided by RefSeq, Jun 2014]
[中文简述(自动翻译):]  由该基因编码的蛋白质,谷胱甘肽S-转移酶(GST)THETA 1(GSTT1),是催化还原谷胱甘肽缀合到各种电和疏水性化合物的蛋白的超家族中的一员。人类的GSTs可分为五个主要类别:α,亩,PI,theta和泽塔。西塔类包括GSTT1和GSTT2。 GSTT1和GSTT2共享55%的氨基酸序列同一性和两者可在人类癌中起重要作用。的GSTT1和GSTT2基因具有相似的结构,被构成的具有相同的外显子/??内含子边界5个外显子。这GSTT1基因是单倍型特异性,是从人口的38%存在。这个基因的选择性剪接的结果在多个转录变体。两个相关的假基因,它们也位于22号染色体上,已经确定。 [由RefSeq的,2014年6月提供]
GSTT1基因(以及对应的蛋白质)的细胞分布位置:
GSTT1基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Lung Neoplasms | 0.168189472 | 20 | 0 | CTD_human_GAD_LHGDN |
Chromosome Aberrations | 0.153138448 | 17 | 0 | CTD_human_GAD |
Hypertensive disease | 0.145275227 | 17 | 0 | BeFree_CTD_human_GAD_LHGDN |
Drug-Induced Liver Injury | 0.14367032 | 10 | 0 | CTD_human_GAD |
Prostatic Neoplasms | 0.140365529 | 12 | 0 | CTD_human_GAD_LHGDN |
Kidney Neoplasm | 0.13183516 | 5 | 0 | CTD_human_GAD |
Renal Cell Carcinoma | 0.13062984 | 14 | 0 | BeFree_CTD_human_GAD |
Multiple Myeloma | 0.125819831 | 5 | 0 | BeFree_CTD_human_GAD |
Amphetamine-Related Disorders | 0.124734064 | 2 | 0 | CTD_human_GAD |
Glioblastoma | 0.123267234 | 2 | 0 | BeFree_CTD_human_LHGDN |
Asbestosis | 0.122909916 | 2 | 0 | BeFree_CTD_human_GAD |
Raynaud Disease | 0.122367032 | 1 | 0 | CTD_human_GAD |
Squamous cell carcinoma of esophagus | 0.121357209 | 5 | 0 | BeFree_CTD_human |
Non-alcoholic Fatty Liver Disease | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Asthenozoospermia | 0.12 | 1 | 0 | CTD_human |
Micronuclei, Chromosome-Defective | 0.12 | 1 | 0 | CTD_human |
Malignant neoplasm of lung | 0.10035814 | 103 | 6 | BeFree_GAD |
Malignant neoplasm of breast | 0.09601507 | 83 | 16 | BeFree_GAD |
Squamous cell carcinoma | 0.095783355 | 51 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of urinary bladder | 0.092757768 | 60 | 5 | BeFree_GAD |
Colorectal Cancer | 0.091943442 | 63 | 0 | BeFree_GAD |
Diabetes Mellitus, Insulin-Dependent | 0.08764398 | 6 | 0 | BeFree_GAD_RGD |
Malignant neoplasm of prostate | 0.08132575 | 53 | 4 | BeFree_GAD |
Stomach Neoplasms | 0.073068993 | 27 | 0 | BeFree_GAD_LHGDN |
DNA Damage | 0.071010959 | 30 | 0 | GAD |
Asthma | 0.061485411 | 34 | 0 | BeFree_GAD_LHGDN |
Head and Neck Neoplasms | 0.052074704 | 22 | 0 | GAD |
Leukemia, Myelocytic, Acute | 0.045730513 | 31 | 0 | BeFree_GAD_LHGDN |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.045049552 | 26 | 0 | BeFree_GAD |
Adenocarcinoma | 0.044949863 | 21 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of esophagus | 0.036938634 | 22 | 0 | BeFree_GAD |
Mouth Neoplasms | 0.035862798 | 15 | 0 | GAD_LHGDN |
Coronary Artery Disease | 0.035729433 | 17 | 0 | BeFree_GAD_LHGDN |
Liver carcinoma | 0.035362183 | 25 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of stomach | 0.034256553 | 45 | 3 | BeFree_GAD |
Esophageal Neoplasms | 0.031661686 | 19 | 0 | BeFree_GAD |
leukemia | 0.030562106 | 14 | 0 | BeFree_GAD_LHGDN |
Endometriosis | 0.030552175 | 16 | 0 | BeFree_GAD_LHGDN |
Colorectal Neoplasms | 0.029833657 | 11 | 0 | GAD_LHGDN |
Mammary Neoplasms | 0.029253216 | 11 | 0 | GAD_LHGDN |
Uterine Cervical Neoplasm | 0.028675826 | 12 | 0 | BeFree_GAD |
Cancer of Head and Neck | 0.027741948 | 24 | 2 | BeFree_GAD |
Chronic Obstructive Airway Disease | 0.025298971 | 14 | 0 | BeFree_GAD |
Thyroid Neoplasm | 0.024384956 | 8 | 0 | GAD_LHGDN |
Malignant neoplasm of ovary | 0.024289148 | 14 | 0 | BeFree_GAD |
Liver neoplasms | 0.023941762 | 11 | 0 | BeFree_GAD |
Bladder Neoplasm | 0.023004003 | 8 | 5 | BeFree_GAD_LHGDN |
Parkinson Disease | 0.02157473 | 10 | 0 | BeFree_GAD |
MYELODYSPLASTIC SYNDROME | 0.020922225 | 12 | 0 | BeFree_GAD_LHGDN |
Brain Neoplasms | 0.020650783 | 11 | 0 | BeFree_GAD_LHGDN |
Carcinoma of lung | 0.02035814 | 75 | 6 | BeFree |
Myeloid Leukemia, Chronic | 0.020097968 | 16 | 1 | BeFree_GAD |
Atherosclerosis | 0.020022023 | 10 | 0 | BeFree_GAD |
Adenoma | 0.019293574 | 7 | 0 | GAD_LHGDN |
Diabetes Mellitus, Non-Insulin-Dependent | 0.01827382 | 18 | 0 | BeFree_GAD |
Lymphoma, Non-Hodgkin | 0.017469426 | 9 | 1 | BeFree_GAD_LHGDN |
Male infertility | 0.016916611 | 15 | 0 | BeFree_GAD |
Laryngeal neoplasm | 0.016569224 | 7 | 0 | GAD |
Myeloid Leukemia | 0.016569224 | 7 | 0 | GAD |
Prenatal Exposure Delayed Effects | 0.016569224 | 7 | 0 | GAD |
Breast Carcinoma | 0.016286512 | 60 | 16 | BeFree |
Cataract | 0.015645278 | 7 | 0 | BeFree_GAD_LHGDN |
Hodgkin Disease | 0.015559401 | 10 | 0 | BeFree_GAD |
Coronary heart disease | 0.015363904 | 16 | 0 | BeFree_GAD |
Chronic Lymphocytic Leukemia | 0.014830952 | 5 | 0 | BeFree_GAD_LHGDN |
Cleft Palate | 0.014473634 | 6 | 0 | BeFree_GAD |
Premature Birth | 0.014202192 | 6 | 0 | GAD |
Rheumatoid Arthritis | 0.014092571 | 8 | 0 | BeFree_GAD_LHGDN |
Lupus Erythematosus, Systemic | 0.013463811 | 8 | 0 | BeFree_GAD |
Myocardial Infarction | 0.013278246 | 7 | 0 | BeFree_GAD_LHGDN |
Carcinoma of bladder | 0.012757768 | 47 | 5 | BeFree |
Pancreatitis | 0.012735362 | 5 | 0 | BeFree_GAD_LHGDN |
Liver Cirrhosis | 0.012649486 | 6 | 0 | BeFree_GAD |
Malignant neoplasm of mouth | 0.012258492 | 21 | 4 | BeFree_GAD |
Glaucoma, Open-Angle | 0.012192478 | 4 | 0 | GAD_LHGDN |
Cleft Lip | 0.012106602 | 5 | 0 | BeFree_GAD |
Liver diseases | 0.01183516 | 5 | 0 | GAD |
Helicobacter Infections | 0.01183516 | 5 | 0 | GAD |
Papillomavirus Infections | 0.01183516 | 5 | 0 | GAD |
Colorectal Carcinoma | 0.011672 | 43 | 0 | BeFree |
Tuberculosis | 0.011368221 | 11 | 0 | BeFree_GAD |
Aplastic Anemia | 0.011182656 | 6 | 0 | BeFree_GAD_LHGDN |
Stomach Carcinoma | 0.010857675 | 40 | 3 | BeFree |
Glioma | 0.010553895 | 8 | 0 | BeFree_GAD |
Prostate carcinoma | 0.010314791 | 38 | 4 | BeFree |
Cervical Intraepithelial Neoplasia | 0.010282454 | 5 | 0 | BeFree_GAD |
Neoplasm Metastasis | 0.010096888 | 4 | 0 | BeFree_GAD_LHGDN |
Deafness | 0.009468128 | 4 | 0 | GAD |
Fetal Growth Retardation | 0.009468128 | 4 | 0 | GAD |
Hearing Loss, Partial | 0.009468128 | 4 | 0 | GAD |
Inflammation | 0.009468128 | 4 | 0 | GAD |
Pre-Eclampsia | 0.009468128 | 4 | 0 | GAD |
Dermatologic disorders | 0.009468128 | 4 | 0 | GAD |
Skin Neoplasms | 0.009468128 | 4 | 0 | GAD |
hearing impairment | 0.009468128 | 4 | 0 | GAD |
Hearing Loss | 0.009468128 | 4 | 0 | GAD |
melanoma | 0.009272631 | 9 | 0 | BeFree_GAD |
Diabetes Mellitus | 0.009087065 | 7 | 0 | BeFree_GAD_LHGDN |
Leukemia, Lymphocytic, Acute, L1 | 0.009001189 | 9 | 0 | BeFree_GAD |
Schizophrenia | 0.008729747 | 7 | 0 | BeFree_GAD |
Kidney Failure, Chronic | 0.008544182 | 4 | 2 | BeFree_GAD_LHGDN |
Lymphoma | 0.008544182 | 7 | 1 | BeFree_GAD_LHGDN |
Carcinoma, Transitional Cell | 0.008186863 | 6 | 0 | BeFree_GAD |
Vitiligo | 0.008186863 | 5 | 0 | BeFree_GAD |
Colonic Neoplasms | 0.008001298 | 4 | 0 | BeFree_GAD_LHGDN |
Dermatitis, Atopic | 0.008001298 | 3 | 0 | BeFree_GAD_LHGDN |
Hepatitis B | 0.007915422 | 5 | 0 | BeFree_GAD |
Varicocele | 0.007915422 | 4 | 0 | BeFree_GAD |
ovarian neoplasm | 0.007729856 | 4 | 0 | BeFree_GAD_LHGDN |
Graft-vs-Host Disease | 0.00764398 | 5 | 0 | BeFree_GAD |
Skin carcinoma | 0.00764398 | 4 | 0 | BeFree_GAD |
Squamous cell carcinoma of the head and neck | 0.007524428 | 19 | 2 | BeFree_GAD |
Alzheimer's Disease | 0.007458414 | 2 | 0 | GAD_LHGDN |
Nephrotic Syndrome | 0.007458414 | 2 | 0 | GAD_LHGDN |
Barrett Esophagus | 0.007372538 | 3 | 0 | BeFree_GAD |
Cystic Fibrosis | 0.007372538 | 4 | 0 | BeFree_GAD |
Diabetic Nephropathy | 0.007372538 | 3 | 0 | BeFree_GAD |
Liver Cirrhosis, Alcoholic | 0.007372538 | 3 | 0 | BeFree_GAD |
Malignant neoplasm of liver | 0.007372538 | 4 | 0 | BeFree_GAD |
Carcinoma, Papillary | 0.007101096 | 3 | 0 | GAD |
Neoplastic Cell Transformation | 0.007101096 | 3 | 0 | GAD |
Hepatitis, Toxic | 0.007101096 | 3 | 0 | GAD |
Testicular Neoplasms | 0.007101096 | 3 | 0 | GAD |
Tobacco Use Disorder | 0.007101096 | 3 | 0 | GAD |
Tuberculosis, Pulmonary | 0.007101096 | 3 | 0 | GAD |
Prostatic Hyperplasia | 0.007101096 | 3 | 0 | GAD |
Preleukemia | 0.006905599 | 10 | 0 | BeFree_GAD |
Leukoplakia, Oral | 0.006091273 | 5 | 4 | BeFree_GAD |
Malignant neoplasm of pancreas | 0.006091273 | 6 | 0 | BeFree_GAD |
Cardiovascular Diseases | 0.005905708 | 3 | 0 | BeFree_GAD_LHGDN |
Inflammatory Bowel Diseases | 0.005905708 | 3 | 0 | BeFree_GAD_LHGDN |
Small cell carcinoma of lung | 0.005905708 | 5 | 0 | BeFree_GAD_LHGDN |
Age related macular degeneration | 0.005905708 | 4 | 0 | BeFree_GAD_LHGDN |
Leukoplakia | 0.005819831 | 4 | 11 | BeFree_GAD |
Esophageal carcinoma | 0.005624334 | 13 | 0 | BeFree_GAD |
Astrocytoma | 0.00554839 | 5 | 0 | BeFree_GAD |
Diffuse Large B-Cell Lymphoma | 0.00554839 | 4 | 2 | BeFree_GAD |
Carcinogenesis | 0.005428837 | 20 | 0 | BeFree |
Drug Eruptions | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Mucosa-Associated Lymphoid Tissue Lymphoma | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Juvenile arthritis | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Balkan Nephropathy | 0.005276948 | 3 | 0 | BeFree_GAD |
Peptic Esophagitis | 0.005276948 | 2 | 0 | BeFree_GAD |
Alcoholic Liver Diseases | 0.005276948 | 2 | 0 | BeFree_GAD |
Lymphoma, Follicular | 0.005276948 | 2 | 0 | BeFree_GAD |
oligodendroglioma | 0.005276948 | 4 | 0 | BeFree_GAD |
Behcet Syndrome | 0.005091382 | 1 | 0 | GAD_LHGDN |
Chorioamnionitis | 0.005091382 | 1 | 0 | GAD_LHGDN |
Cervix carcinoma | 0.005081451 | 10 | 0 | BeFree_GAD |
Alcoholic Intoxication, Chronic | 0.005005506 | 3 | 0 | BeFree_GAD |
Gastroesophageal reflux disease | 0.005005506 | 2 | 0 | BeFree_GAD |
Neoplasms, Multiple Primary | 0.005005506 | 2 | 0 | BeFree_GAD |
Obesity | 0.005005506 | 3 | 0 | BeFree_GAD |
Peripheral Neuropathy | 0.005005506 | 3 | 1 | BeFree_GAD |
Respiratory Tract Diseases | 0.005005506 | 3 | 0 | BeFree_GAD |
Motor Neuron Disease | 0.005005506 | 3 | 0 | BeFree_GAD |
Exfoliation Syndrome | 0.005005506 | 2 | 0 | BeFree_GAD |
beta Thalassemia | 0.004734064 | 2 | 0 | GAD |
Basal cell carcinoma | 0.004734064 | 2 | 0 | GAD |
Brain Ischemia | 0.004734064 | 2 | 0 | GAD |
Chromosome Deletion | 0.004734064 | 2 | 0 | GAD |
Cocarcinogenesis | 0.004734064 | 2 | 0 | GAD |
Pathological accumulation of air in tissues | 0.004734064 | 2 | 0 | GAD |
Epilepsy | 0.004734064 | 2 | 0 | GAD |
Noise-induced hearing loss | 0.004734064 | 2 | 0 | GAD |
Hypersensitivity | 0.004734064 | 2 | 0 | GAD |
Animal Mammary Neoplasms | 0.004734064 | 2 | 0 | GAD |
Nasopharyngeal Neoplasms | 0.004734064 | 2 | 0 | GAD |
Oropharyngeal Neoplasms | 0.004734064 | 2 | 0 | GAD |
Pancreatic Neoplasm | 0.004734064 | 2 | 0 | GAD |
Adenomatous Polyposis Coli | 0.004734064 | 2 | 0 | GAD |
Presbycusis | 0.004734064 | 2 | 0 | GAD |
Chromosomal translocation | 0.004734064 | 2 | 0 | GAD |
Urologic Neoplasms | 0.004734064 | 2 | 0 | GAD |
Neoplasms, Second Primary | 0.004734064 | 2 | 0 | GAD |
Arsenic Poisoning | 0.004734064 | 2 | 0 | GAD |
Chromosome Breakage | 0.004734064 | 2 | 0 | GAD |
Pancreatitis, Alcoholic | 0.004734064 | 2 | 0 | GAD |
Hepatitis B, Chronic | 0.004734064 | 2 | 0 | GAD |
Hepatitis C, Chronic | 0.004734064 | 2 | 0 | GAD |
Congenital chromosomal disease | 0.004614512 | 17 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.004614512 | 17 | 4 | BeFree |
Malignant neoplasm of larynx | 0.004538567 | 8 | 0 | BeFree_GAD |
Glaucoma | 0.004267125 | 7 | 0 | BeFree_GAD |
Thyroid carcinoma | 0.004267125 | 8 | 0 | BeFree_GAD |
Hepatitis | 0.003810118 | 5 | 0 | BeFree_LHGDN |
Coronary Arteriosclerosis | 0.003528744 | 13 | 0 | BeFree |
Acute lymphocytic leukemia | 0.003528744 | 13 | 0 | BeFree |
Arteriosclerosis | 0.003452799 | 5 | 0 | BeFree_GAD |
Cancer of Nasopharynx | 0.003452799 | 5 | 0 | BeFree_GAD |
Ovarian Carcinoma | 0.003257302 | 12 | 0 | BeFree |
Ulcerative Colitis | 0.003181358 | 4 | 0 | BeFree_GAD |
Autoimmune Diseases | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Hepatitis, Autoimmune | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Congenital Abnormality | 0.002909916 | 3 | 1 | BeFree_GAD |
Crohn Disease | 0.002909916 | 3 | 0 | BeFree_GAD |
Neutropenia | 0.002909916 | 3 | 1 | BeFree_GAD |
Osteosarcoma | 0.002909916 | 3 | 0 | BeFree_GAD |
Peptic Ulcer | 0.002909916 | 2 | 0 | BeFree_GAD |
Psoriasis | 0.002909916 | 2 | 0 | BeFree_GAD |
Rectal Neoplasms | 0.002909916 | 3 | 0 | BeFree_GAD |
Sudden infant death syndrome | 0.002909916 | 2 | 0 | BeFree_GAD |
Pancreatitis, Chronic | 0.002909916 | 2 | 0 | BeFree_GAD |
Malignant neoplasm of kidney | 0.002909916 | 2 | 0 | BeFree_GAD |
Hypospadias | 0.002909916 | 2 | 0 | BeFree_GAD |
Carotid Artery Diseases | 0.00272435 | 1 | 0 | LHGDN |
Fibrosis | 0.00272435 | 1 | 0 | LHGDN |
gallbladder neoplasm | 0.00272435 | 1 | 0 | LHGDN |
Metaplasia | 0.00272435 | 1 | 0 | LHGDN |
Periodontitis, Juvenile | 0.00272435 | 1 | 0 | LHGDN |
Mental Depression | 0.002638474 | 1 | 0 | BeFree_GAD |
Eclampsia | 0.002638474 | 1 | 0 | BeFree_GAD |
Esophageal Atresia | 0.002638474 | 1 | 0 | BeFree_GAD |
Disorder of eye | 0.002638474 | 2 | 0 | BeFree_GAD |
Fanconi Anemia | 0.002638474 | 1 | 0 | BeFree_GAD |
Graves Disease | 0.002638474 | 1 | 0 | BeFree_GAD |
Sensorineural Hearing Loss (disorder) | 0.002638474 | 1 | 0 | BeFree_GAD |
Hepatitis C | 0.002638474 | 2 | 0 | BeFree_GAD |
HIV Infections | 0.002638474 | 2 | 0 | BeFree_GAD |
Neonatal Jaundice | 0.002638474 | 2 | 0 | BeFree_GAD |
Kidney Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
Lymphoid leukemia | 0.002638474 | 2 | 0 | BeFree_GAD |
Medulloblastoma | 0.002638474 | 1 | 0 | BeFree_GAD |
Occupational Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
Disorder of the optic nerve | 0.002638474 | 1 | 0 | BeFree_GAD |
Degenerative polyarthritis | 0.002638474 | 2 | 0 | BeFree_GAD |
Pneumonia | 0.002638474 | 1 | 0 | BeFree_GAD |
Polycystic Ovary Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
Respiration Disorders | 0.002638474 | 2 | 0 | BeFree_GAD |
Rosacea | 0.002638474 | 1 | 0 | BeFree_GAD |
Thyroid Nodule | 0.002638474 | 1 | 0 | BeFree_GAD |
Malignant neoplasm of gallbladder | 0.002638474 | 1 | 0 | BeFree_GAD |
HELLP Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
childhood brain tumor | 0.002638474 | 2 | 0 | BeFree_GAD |
Malignant mesothelioma | 0.002638474 | 2 | 0 | BeFree_GAD |
Malignant tumor of cervix | 0.002442977 | 9 | 0 | BeFree |
Spontaneous abortion | 0.002367032 | 1 | 0 | GAD |
Abortion, Habitual | 0.002367032 | 1 | 0 | GAD |
Altitude Sickness | 0.002367032 | 1 | 0 | GAD |
Aneuploidy | 0.002367032 | 1 | 0 | GAD |
Arthritis | 0.002367032 | 1 | 0 | GAD |
Ascorbic Acid Deficiency | 0.002367032 | 1 | 0 | GAD |
Asphyxia Neonatorum | 0.002367032 | 1 | 0 | GAD |
Bone Marrow Diseases | 0.002367032 | 1 | 0 | GAD |
Bronchitis | 0.002367032 | 1 | 0 | GAD |
Cerebellar Neoplasms | 0.002367032 | 1 | 0 | GAD |
Cerebral Infarction | 0.002367032 | 1 | 0 | GAD |
Cerebrovascular Disorders | 0.002367032 | 1 | 0 | GAD |
Connective Tissue Diseases | 0.002367032 | 1 | 0 | GAD |
Hearing Loss, Sudden | 0.002367032 | 1 | 0 | GAD |
Down Syndrome | 0.002367032 | 1 | 0 | GAD |
Drug toxicity | 0.002367032 | 1 | 0 | GAD |
Duodenal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Dyskinesia, Drug-Induced | 0.002367032 | 1 | 0 | GAD |
Dysmenorrhea | 0.002367032 | 1 | 0 | GAD |
Dyspepsia | 0.002367032 | 1 | 0 | GAD |
Edema | 0.002367032 | 1 | 0 | GAD |
Ehlers-Danlos Syndrome | 0.002367032 | 1 | 0 | GAD |
Endometrial Neoplasms | 0.002367032 | 1 | 0 | GAD |
Ependymoma | 0.002367032 | 1 | 0 | GAD |
Fatty Liver | 0.002367032 | 1 | 0 | GAD |
Fatty Liver, Alcoholic | 0.002367032 | 1 | 0 | GAD |
Fetal Diseases | 0.002367032 | 1 | 0 | GAD |
Gastritis | 0.002367032 | 1 | 0 | GAD |
Gastrointestinal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Female Genital Diseases | 0.002367032 | 1 | 0 | GAD |
Hamartoma | 0.002367032 | 1 | 0 | GAD |
Hearing Loss, High-Frequency | 0.002367032 | 1 | 0 | GAD |
Hematological Disease | 0.002367032 | 1 | 0 | GAD |
Hemoglobinopathies | 0.002367032 | 1 | 0 | GAD |
Hepatic Veno-Occlusive Disease | 0.002367032 | 1 | 0 | GAD |
Hepatitis, Chronic | 0.002367032 | 1 | 0 | GAD |
Actinic keratosis | 0.002367032 | 1 | 0 | GAD |
Premature Obstetric Labor | 0.002367032 | 1 | 0 | GAD |
Leukemia, Lymphocytic, Acute, L2 | 0.002367032 | 1 | 0 | GAD |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.002367032 | 1 | 0 | GAD |
Biliary cirrhosis | 0.002367032 | 1 | 0 | GAD |
Lymphatic Metastasis | 0.002367032 | 1 | 0 | GAD |
Malaria, Falciparum | 0.002367032 | 1 | 0 | GAD |
Multiple Sclerosis | 0.002367032 | 1 | 0 | GAD |
Musculoskeletal Diseases | 0.002367032 | 1 | 0 | GAD |
Neoplasm Invasiveness | 0.002367032 | 1 | 0 | GAD |
Neoplasm Recurrence, Local | 0.002367032 | 1 | 0 | GAD |
Neoplasms, Radiation-Induced | 0.002367032 | 1 | 0 | GAD |
nervous system disorder | 0.002367032 | 1 | 0 | GAD |
Dermatitis, Occupational | 0.002367032 | 1 | 0 | GAD |
Ocular Hypertension | 0.002367032 | 1 | 0 | GAD |
Periodontitis | 0.002367032 | 1 | 0 | GAD |
Pharyngeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Pituitary Neoplasms | 0.002367032 | 1 | 0 | GAD |
Postoperative Complications | 0.002367032 | 1 | 0 | GAD |
Pregnancy Complications | 0.002367032 | 1 | 0 | GAD |
Pregnancy Complications, Hematologic | 0.002367032 | 1 | 0 | GAD |
Protein-Energy Malnutrition | 0.002367032 | 1 | 0 | GAD |
Proteinuria | 0.002367032 | 1 | 0 | GAD |
Pseudomonas Infections | 0.002367032 | 1 | 0 | GAD |
Respiratory Distress Syndrome, Newborn | 0.002367032 | 1 | 0 | GAD |
Respiratory Distress Syndrome, Adult | 0.002367032 | 1 | 0 | GAD |
Respiratory Hypersensitivity | 0.002367032 | 1 | 0 | GAD |
Respiratory Tract Neoplasms | 0.002367032 | 1 | 0 | GAD |
Rhinitis, Allergic, Perennial | 0.002367032 | 1 | 0 | GAD |
Stomach Diseases | 0.002367032 | 1 | 0 | GAD |
Sunburn | 0.002367032 | 1 | 0 | GAD |
Trisomy | 0.002367032 | 1 | 0 | GAD |
Tumor Virus Infections | 0.002367032 | 1 | 0 | GAD |
Erythema | 0.002367032 | 1 | 0 | GAD |
T-Cell Lymphoma | 0.002367032 | 1 | 0 | GAD |
Ovarian Failure, Premature | 0.002367032 | 1 | 0 | GAD |
Migraine Disorders | 0.002367032 | 1 | 0 | GAD |
Lingual-Facial-Buccal Dyskinesia | 0.002367032 | 1 | 0 | GAD |
Low Tension Glaucoma | 0.002367032 | 1 | 0 | GAD |
Dermatitis, Allergic Contact | 0.002367032 | 1 | 0 | GAD |
Germinoma | 0.002367032 | 1 | 0 | GAD |
Papillary and follicular adenocarcinoma | 0.002367032 | 1 | 0 | GAD |
Carcinoma, Large Cell | 0.002367032 | 1 | 0 | GAD |
Neurotoxicity Syndromes | 0.002367032 | 1 | 0 | GAD |
Ototoxicity | 0.002367032 | 1 | 0 | GAD |
Alcohol-Related Disorders | 0.002367032 | 1 | 0 | GAD |
Dyslipidemias | 0.002367032 | 1 | 0 | GAD |
Acute Lung Injury | 0.002367032 | 1 | 0 | GAD |
Oxidative Stress | 0.002367032 | 1 | 0 | GAD |
Multiple Chemical Sensitivity | 0.002367032 | 1 | 0 | GAD |
Hearing problem | 0.002367032 | 1 | 0 | GAD |
Carcinoma, Small Cell | 0.002367032 | 1 | 0 | GAD |
Iron Overload | 0.002367032 | 1 | 0 | GAD |
Atrophic | 0.002367032 | 1 | 0 | GAD |
Hematologic Neoplasms | 0.002367032 | 1 | 0 | GAD |
Chronic Kidney Insufficiency | 0.002367032 | 1 | 0 | GAD |
Neuropathy | 0.002367032 | 1 | 0 | GAD |
Toxic effect of formaldehyde | 0.002367032 | 1 | 0 | GAD |
Methotrexate poisoning | 0.002367032 | 1 | 0 | GAD |
Tardive Dyskinesia | 0.002367032 | 1 | 0 | GAD |
Organophosphate poisoning | 0.002367032 | 1 | 0 | GAD |
Cardiomyopathies | 0.002367032 | 1 | 0 | GAD |
Sarcoma | 0.002367032 | 1 | 0 | GAD |
Mesothelioma (malignant, clinical disorder) (disorder) | 0.002367032 | 1 | 0 | GAD |
Oxyphilic Adenoma | 0.002367032 | 1 | 0 | GAD |
Sjogren's Syndrome | 0.002367032 | 1 | 0 | GAD |
MUTAGEN SENSITIVITY | 0.002367032 | 1 | 0 | GAD |
Proteinuria Adverse Event | 0.002367032 | 1 | 0 | GAD |
Airway Remodeling | 0.002367032 | 1 | 0 | GAD |
Drug-Induced Liver Injury, Chronic | 0.002367032 | 1 | 0 | GAD |
Chronic ulcerative colitis | 0.002367032 | 1 | 0 | GAD |
Solar Erythema | 0.002367032 | 1 | 0 | GAD |
Infection | 0.002367032 | 1 | 0 | GAD |
Mountain Sickness | 0.002367032 | 1 | 0 | GAD |
Malignant tumor of colon | 0.002171535 | 8 | 0 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.001900093 | 7 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.001628651 | 6 | 0 | BeFree |
Age-related cataract | 0.001628651 | 6 | 0 | BeFree |
Glaucoma, Primary Open Angle | 0.001628651 | 6 | 0 | BeFree |
Epithelial ovarian cancer | 0.001628651 | 6 | 0 | BeFree |
Colon Carcinoma | 0.001628651 | 6 | 0 | BeFree |
Nasopharyngeal carcinoma | 0.001628651 | 6 | 0 | BeFree |
Acute leukemia | 0.001357209 | 5 | 0 | BeFree |
Pancreatic carcinoma | 0.001357209 | 5 | 0 | BeFree |
Carcinoma of larynx | 0.001357209 | 5 | 0 | BeFree |
hepatitis immune | 0.001357209 | 5 | 0 | BeFree |
Helicobacter pylori infection | 0.001357209 | 5 | 0 | BeFree |
Adenoma of large intestine | 0.001357209 | 5 | 0 | BeFree |
Diabetes | 0.001085767 | 4 | 0 | BeFree |
Hepatitis A | 0.001085767 | 4 | 0 | BeFree |
Meningioma | 0.001085767 | 4 | 0 | BeFree |
Kidney Failure | 0.001085767 | 4 | 2 | BeFree |
Malignant neoplasm of nasopharynx | 0.001085767 | 4 | 0 | BeFree |
Tumor Progression | 0.001085767 | 4 | 0 | BeFree |
Acquired aplastic anemia | 0.001085767 | 4 | 0 | BeFree |
Non-Neoplastic Disorder | 0.001085767 | 4 | 0 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.001085767 | 4 | 0 | BeFree |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.001085767 | 4 | 0 | BeFree |
Azoospermia | 0.000814326 | 3 | 0 | BeFree |
Non-Small Cell Lung Carcinoma | 0.000814326 | 3 | 4 | BeFree |
Leukopenia | 0.000814326 | 3 | 1 | BeFree |
Oligospermia | 0.000814326 | 3 | 0 | BeFree |
Oral Submucous Fibrosis | 0.000814326 | 3 | 0 | BeFree |
Wheezing | 0.000814326 | 3 | 0 | BeFree |
Essential Hypertension | 0.000814326 | 3 | 0 | BeFree |
Cutaneous Melanoma | 0.000814326 | 3 | 0 | BeFree |
Adenocarcinoma of lung (disorder) | 0.000814326 | 3 | 0 | BeFree |
Acute myocardial infarction | 0.000814326 | 3 | 0 | BeFree |
Adult Acute Myeloblastic Leukemia | 0.000814326 | 3 | 0 | BeFree |
Papillary thyroid carcinoma | 0.000814326 | 3 | 0 | BeFree |
Adenocarcinoma Of Esophagus | 0.000814326 | 3 | 0 | BeFree |
Endometrial Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Carotid Atherosclerosis | 0.000814326 | 3 | 3 | BeFree |
Sporadic Breast Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Benign Prostatic Hyperplasia | 0.000814326 | 3 | 0 | BeFree |
Slow acetylator due to N-acetyltransferase enzyme variant | 0.000814326 | 3 | 0 | BeFree |
Uterine Corpus Cancer | 0.000814326 | 3 | 0 | BeFree |
Acute pancreatitis | 0.000542884 | 2 | 0 | BeFree |
AIDS related complex | 0.000542884 | 2 | 0 | BeFree |
Anemia | 0.000542884 | 2 | 0 | BeFree |
Anemia, Sickle Cell | 0.000542884 | 2 | 0 | BeFree |
Anxiety Disorders | 0.000542884 | 2 | 0 | BeFree |
Bronchopulmonary Dysplasia | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of endometrium | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of skin | 0.000542884 | 2 | 0 | BeFree |
Cervical dysplasia | 0.000542884 | 2 | 0 | BeFree |
Diabetic Retinopathy | 0.000542884 | 2 | 0 | BeFree |
Eczema | 0.000542884 | 2 | 0 | BeFree |
Exanthema | 0.000542884 | 2 | 7 | BeFree |
Gastritis, Atrophic | 0.000542884 | 2 | 0 | BeFree |
Acute Promyelocytic Leukemia | 0.000542884 | 2 | 0 | BeFree |
Myelodysplasia | 0.000542884 | 2 | 0 | BeFree |
Nasal Polyps | 0.000542884 | 2 | 0 | BeFree |
Osteoporosis | 0.000542884 | 2 | 0 | BeFree |
Precancerous Conditions | 0.000542884 | 2 | 0 | BeFree |
Cerebrovascular accident | 0.000542884 | 2 | 0 | BeFree |
Chronic gastritis | 0.000542884 | 2 | 0 | BeFree |
Oral Cavity Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Allergic asthma | 0.000542884 | 2 | 0 | BeFree |
Adrenoleukodystrophy | 0.000542884 | 2 | 0 | BeFree |
Dysplastic Nevus | 0.000542884 | 2 | 0 | BeFree |
Congenital defects | 0.000542884 | 2 | 0 | BeFree |
Cortical cataract | 0.000542884 | 2 | 0 | BeFree |
Gastric Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Transitional cell carcinoma of bladder | 0.000542884 | 2 | 0 | BeFree |
Solid tumour | 0.000542884 | 2 | 2 | BeFree |
Laryngeal Squamous Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
High-Grade Squamous Intraepithelial Lesions | 0.000542884 | 2 | 0 | BeFree |
Anaplastic Oligodendroglioma | 0.000542884 | 2 | 0 | BeFree |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
Malignant Glioma | 0.000542884 | 2 | 0 | BeFree |
Osteosarcoma of bone | 0.000542884 | 2 | 0 | BeFree |
Gastro-esophageal reflux disease with esophagitis | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of gastrointestinal tract | 0.000542884 | 2 | 0 | BeFree |
Well Differentiated Oligodendroglioma | 0.000542884 | 2 | 0 | BeFree |
Spots on skin | 0.000542884 | 2 | 7 | BeFree |
precancerous lesions | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma of large intestine | 0.000542884 | 2 | 0 | BeFree |
Childhood Leukemia | 0.000542884 | 2 | 1 | BeFree |
Hereditary Nonpolyposis Colorectal Cancer | 0.000542884 | 2 | 0 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Renal carcinoma | 0.000542884 | 2 | 0 | BeFree |
Rectal Tumors | 0.000542884 | 2 | 0 | BeFree |
Chronic Kidney Diseases | 0.000542884 | 2 | 0 | BeFree |
Penile hypospadias | 0.000542884 | 2 | 0 | BeFree |
Urothelial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Cooley's anemia | 0.000271442 | 1 | 0 | BeFree |
Asthenia | 0.000271442 | 1 | 1 | BeFree |
Basal Cell Nevus Syndrome | 0.000271442 | 1 | 0 | BeFree |
Bipolar Disorder | 0.000271442 | 1 | 0 | BeFree |
Borderline Personality Disorder | 0.000271442 | 1 | 0 | BeFree |
Brain Diseases | 0.000271442 | 1 | 0 | BeFree |
Bronchiolitis | 0.000271442 | 1 | 0 | BeFree |
Bronchogenic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Carpal Tunnel Syndrome | 0.000271442 | 1 | 0 | BeFree |
Cervix Diseases | 0.000271442 | 1 | 0 | BeFree |
Primary biliary cirrhosis | 0.000271442 | 1 | 0 | BeFree |
Cholangitis, Sclerosing | 0.000271442 | 1 | 0 | BeFree |
Bronchitis, Chronic | 0.000271442 | 1 | 0 | BeFree |
Colonic Diseases | 0.000271442 | 1 | 0 | BeFree |
Diabetic Neuropathies | 0.000271442 | 1 | 0 | BeFree |
Diarrhea | 0.000271442 | 1 | 1 | BeFree |
Immune System Diseases | 0.000271442 | 1 | 0 | BeFree |
Myasthenia Gravis | 0.000271442 | 1 | 0 | BeFree |
Optic Neuritis | 0.000271442 | 1 | 0 | BeFree |
Polymorphous light eruption | 0.000271442 | 1 | 0 | BeFree |
Polycythemia Vera | 0.000271442 | 1 | 0 | BeFree |
Psychotic Disorders | 0.000271442 | 1 | 0 | BeFree |
Pulmonary Emphysema | 0.000271442 | 1 | 0 | BeFree |
Systemic Scleroderma | 0.000271442 | 1 | 0 | BeFree |
Skin Manifestations | 0.000271442 | 1 | 0 | BeFree |
Temporomandibular Joint Disorders | 0.000271442 | 1 | 0 | BeFree |
Temporomandibular Joint Dysfunction Syndrome | 0.000271442 | 1 | 0 | BeFree |
Venous Insufficiency | 0.000271442 | 1 | 0 | BeFree |
Virus Diseases | 0.000271442 | 1 | 0 | BeFree |
B-Cell Lymphomas | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Large-Cell, Follicular | 0.000271442 | 1 | 1 | BeFree |
Liver Failure | 0.000271442 | 1 | 0 | BeFree |
Burning sensation | 0.000271442 | 1 | 0 | BeFree |
Congenital heart disease | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of pharynx | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of brain | 0.000271442 | 1 | 2 | BeFree |
Chronic berylliosis | 0.000271442 | 1 | 0 | BeFree |
Memory impairment | 0.000271442 | 1 | 0 | BeFree |
Gallbladder Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.000271442 | 1 | 0 | BeFree |
Hereditary pancreatitis | 0.000271442 | 1 | 0 | BeFree |
Fibrosis, Liver | 0.000271442 | 1 | 0 | BeFree |
Bulla of lung | 0.000271442 | 1 | 0 | BeFree |
Childhood asthma | 0.000271442 | 1 | 1 | BeFree |
Miller Dieker syndrome | 0.000271442 | 1 | 0 | BeFree |
Xeroderma Pigmentosum, Complementation Group D | 0.000271442 | 1 | 3 | BeFree |
5,10-Methylenetetrahydrofolate reductase deficiency | 0.000271442 | 1 | 0 | BeFree |
Malignant Childhood Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Cervical Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
secondary acute myeloid leukemia | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of pancreas | 0.000271442 | 1 | 0 | BeFree |
Squamous intraepithelial lesion | 0.000271442 | 1 | 0 | BeFree |
Anaplastic astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Non-arteritic ischemic optic neuropathy | 0.000271442 | 1 | 0 | BeFree |
Optic Atrophy, Autosomal Dominant | 0.000271442 | 1 | 0 | BeFree |
Impaired cognition | 0.000271442 | 1 | 0 | BeFree |
Complicated pneumoconiosis | 0.000271442 | 1 | 0 | BeFree |
Chronic liver disease | 0.000271442 | 1 | 0 | BeFree |
Human papilloma virus infection | 0.000271442 | 1 | 0 | BeFree |
Nonorganic psychosis | 0.000271442 | 1 | 0 | BeFree |
Hematopoietic Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Chromosome 8, trisomy | 0.000271442 | 1 | 0 | BeFree |
Mood Disorders | 0.000271442 | 1 | 0 | BeFree |
Environmental Carcinogenesis | 0.000271442 | 1 | 1 | BeFree |
Primary sclerosing cholangitis | 0.000271442 | 1 | 0 | BeFree |
Leukemogenesis | 0.000271442 | 1 | 0 | BeFree |
early pregnancy | 0.000271442 | 1 | 0 | BeFree |
Cleft Lip with or without Cleft Palate | 0.000271442 | 1 | 0 | BeFree |
Arteriopathic disease | 0.000271442 | 1 | 0 | BeFree |
Invasive breast carcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinogenicity | 0.000271442 | 1 | 0 | BeFree |
Environment-Related Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Colorectal cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Low Grade Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 0.000271442 | 1 | 0 | BeFree |
Gastric Cardia Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Testicular Germ Cell Tumor | 0.000271442 | 1 | 1 | BeFree |
Treatment related acute myeloid leukaemia | 0.000271442 | 1 | 0 | BeFree |
Cervical high grade squamous intraepithelial lesion | 0.000271442 | 1 | 0 | BeFree |
Low Grade Cervical Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Cleft lip, isolated | 0.000271442 | 1 | 0 | BeFree |
TIBIAL MUSCULAR DYSTROPHY, TARDIVE | 0.000271442 | 1 | 0 | BeFree |
Autoimmune pancreatitis | 0.000271442 | 1 | 0 | BeFree |
Allergic disposition | 0.000271442 | 1 | 0 | BeFree |
Juvenile rheumatoid arthritis | 0.000271442 | 1 | 0 | BeFree |
Anemia in children | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。